Related Articles
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer
Therapeutic options in patients with biochemical recurrence after radical prostatectomy (Review)
Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer